New Blog entry at Gibson Consulting on the use of continuous monitoring to detect respiratory depression and compromise.
HIMSS Future Care posting:
Managing patients on the general care floor (GCF) who are either at risk or “diagnosed with obstructive sleep apnea (OSA), and those in particular who meet the requirements of the STOP-BANG criteria for OSA, can be quite challenging. The ECRI Institute, a federally-certified patient safety and research organization, has identified in its 2017 list of Top 10 Health Technology Hazards “Undetected Opioid-Induced Respiratory Depression” as Number 4 . Opioids used for treatment of acute postoperative pain is rather commonplace, and patients at-risk for OSA, if left unattended, can experience anoxic brain injury or death.